Target validation using Phase 0 clinical trials: Promises and pitfalls

Cancer Biol Ther. 2009 Nov;8(21):2010-2. doi: 10.4161/cbt.8.21.10154.
No abstract available

Publication types

  • Comment
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic / methods*
  • Drugs, Investigational / therapeutic use*
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Drugs, Investigational